Company Filing History:
2 out of 52 
2 out of 3 
1 out of 1 Years Active: 2021-2024
Title: Hiroatsu Hirano: Innovator in Corneal Endothelial Cell Research
Introduction
Hiroatsu Hirano is a notable inventor based in Kyotanabe, Japan. He has made significant contributions to the field of corneal endothelial cell research, holding two patents that focus on the purification and preparation of cultured corneal endothelial cells. His work aims to enhance the quality and effectiveness of cell cultures used in medical applications.
Latest Patents
Hirano's latest patents revolve around the development of cell surface markers for corneal endothelial cells. The primary goal of his inventions is to provide methods for distinguishing between normal and transformed corneal endothelial cells. One of the key features of his patents includes the identification of specific cell surface markers, such as CD166 for normal cells and CD73 for transformed cells. By utilizing these markers, researchers can improve the purity of cultured corneal endothelium, which is crucial for various therapeutic applications.
Career Highlights
Throughout his career, Hirano has worked with esteemed organizations, including the Kyoto Prefectural Public University Corporation and Actualeyes Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to advancements in cell culture techniques.
Collaborations
Hirano has collaborated with notable colleagues such as Shigeru Kinoshita and Morio Ueno. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.
Conclusion
Hiroatsu Hirano's innovative work in the field of corneal endothelial cell research has the potential to significantly improve medical treatments involving cell cultures. His contributions through patents and collaborations highlight the importance of ongoing research in this vital area of healthcare.